Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Resmed Inc (RMD) Com Stk USD 0.004

Sell:$134.50 Buy:$134.53 Change: $1.02 (0.76%)
Market closed |  Prices as at close on 20 September 2019 | Switch to live prices |
Sell:$134.50
Buy:$134.53
Change: $1.02 (0.76%)
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account
Market closed |  Prices as at close on 20 September 2019 | Switch to live prices |
Sell:$134.50
Buy:$134.53
Change: $1.02 (0.76%)
Market closed |  Prices as at close on 20 September 2019 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD), neuromuscular disease and other diseases. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. Its cloud-based software digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions. The Company produces Continuous Positive Airway Pressure (CPAP), Variable Positive Airway Pressure (VPAP) and AutoSet systems for the titration and treatment of SDB.

Contact details

Address:
9001 Spectrum Center Blvd
SAN DIEGO
92123-1438
United States
Telephone:
+1 (858) 7462400
Website:
https://www.resmed.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
RMD
ISIN:
US7611521078
Market cap:
$19.05 billion
Shares in issue:
143.67 million
Sector:
Health Care Equipment
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Robert Douglas
    President, Chief Operating Officer
  • Michael Farrell
    Chief Executive Officer, Director
  • Brett Sandercock
    Chief Financial Officer
  • Jim Hollingshead
    President – Sleep Business
  • Richard McHale
    President – Respiratory Care Business
  • Raj Sodhi
    President – Software as a Service (SaaS) Business
  • David Pendarvis
    Chief Administrative Officer, Global General Counsel, Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.